Wikidata

(Q44826910)

English

Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning

scientific article published in April 2004

In more languages

Statements

title
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15059843
retrieved
6 December 2017
author name string
Aloysius Y L Ho
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15059843
retrieved
6 December 2017
Antonio Pagliuca
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15059843
retrieved
6 December 2017
Michelle Kenyon
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15059843
retrieved
6 December 2017
Jane E Parker
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15059843
retrieved
6 December 2017
Aleksandar Mijovic
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15059843
retrieved
6 December 2017
Stephen Devereux
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15059843
retrieved
6 December 2017
Ghulam J Mufti
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15059843
retrieved
6 December 2017
publication date
1 April 2004
1 reference
stated in
Europe PubMed Central
PubMed ID
15059843
retrieved
6 December 2017
page(s)
1616-1623
1 reference
stated in
Europe PubMed Central
PubMed ID
15059843
retrieved
6 December 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44826910&oldid=2047946074"